Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00407147 · ClinicalTrials.gov registry record · Phase 4
Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection
A Phase 4 study, sponsored by Brahms.
- Terminated
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT00407147: Clinical Trial Phase 4 study, sponsored by Brahms.
NCT00407147 is a Phase 4 study that was terminated before completion, run by Brahms. The registered enrollment target is 11 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00407147, a Phase 4 study, was terminated before completion, sponsored by Brahms.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether a U.S. Food and Drug Administration (FDA) approved laboratory test (PCT Kryptor) can help doctors make better decisions on the need for antibiotic therapy in ICU patients with suspected infections.
Interventions
- DEVICE Procalcitonin assay - B.R.A.H.M.S PCT sensitive Kryptor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2008-07 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
Why NCT00407147 stopped before completion
NCT00407147 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Procalcitonin assay - B.R.A.H.M.S PCT sensitive Kryptor is the first listed.
NCT00407147 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00407147 about?
NCT00407147 is a clinical study titled "Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection". The purpose of this study is to test whether a U.S. Food and Drug Administration (FDA) approved laboratory test (PCT Kryptor) can help doctors make better decisions on the need for antibiotic therapy in ICU patients with suspected infections.
What is the current status of trial NCT00407147?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2008-07. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00407147?
The interventions under investigation include: Procalcitonin assay - B.R.A.H.M.S PCT sensitive Kryptor (DEVICE).
Who is sponsoring clinical trial NCT00407147?
This trial is sponsored by Brahms, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00407147's enrollment target sits among peer trials
11 1931st of 2000 higher than 61 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia